• AJMCAJMC
  • Center for Biosimilars
The Center for Biosimilars - Biosimilars, Health Economics & Insights
The Center for Biosimilars - Biosimilars, Health Economics & Insights
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
All News
Product Approvals and Launches
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Stakeholder Summit
Compendia
Bone Health
Dermatology
Diabetes
Gastroenterology
Hematology
Immunology
Neurology
Oncology
Ophthalmology
Rare Disease
Respiratory
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Interactive Tools
Partners
Polls and Quizzes
Sponsored
WHEN CHOICE ARRIVES: Competition & Consequences
SubscribeBIOSIMILAR APPROVALS
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2025 MJH Life Sciences and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Advertisement
Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Editorial
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2025 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Biosimilars and Bone Health

Key considerations for biosimilar use in managing bone health.

EP. 1: Optimizing Biosimilar Treatment Strategies in Bone Health

May 17th 2024

Colin C. Edgerton, MD, discusses key considerations for utilizing biosimilars in the bone health treatment landscape.

EP. 2: Managing Treatment Strategies for Osteoporosis Amid Evolving Biologic and Biosimilar Landscape

May 30th 2024

Jeffrey Curtis, MD, MS, MPH, provides expert perspective for navigating the evolving treatment landscape of osteoporosis and key considerations for biologic and biosimilar utilization.

Advertisement
Advertisement